NCT01463163View on ClinicalTrials.gov

Ticagrelor in Comparison to Prasugrel for Early Inhibition of Platelet Reactivity in Patients With ST-elevation Myocardial Infarction (STEMI), Undergoing Primary Percutaneous Coronary Intervention (PCI)

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

April 30, 2012

Study Completion Date

April 30, 2012

Conditions
Platelet Reactivity
Interventions
DRUG

Prasugrel

Prasugrel 60mg LD followed by 10mg x1 MD starting post 24 hours

DRUG

Ticagrelor

Ticagrelor 180mg LD followed by 90mg x2 MD starting after 12±6 hours

Trial Locations (1)

26500

Cardiology Department Patras University Hospital, Rio

All Listed Sponsors
lead

University of Patras

OTHER

NCT01463163 - Ticagrelor in Comparison to Prasugrel for Early Inhibition of Platelet Reactivity in Patients With ST-elevation Myocardial Infarction (STEMI), Undergoing Primary Percutaneous Coronary Intervention (PCI) | Biotech Hunter | Biotech Hunter